22 May, 2021

2021 AACR: Personalis Product Demo

2021 AACR Personalis Product Demo Advancing Biomarker Discovery: Enabling improved tumor immunogenomics through a comprehensive approach Travis Yates, PhD Field Applications Scientist This presentation will cover: Predicting patient response to immunotherapies requires a robust and comprehensive approach to tumor immunogenomics. By combining highly [...]

13 Apr, 2021

Biomarker Discovery Solutions for Lymphoma & Multiple Myeloma

Biomarker Discovery Solutions for Lymphoma & Multiple Myeloma Comprehensive Characterization of Genetic Events With Combinatorial DNA and RNA Profiling Travis Yates, PhD Field Application Scientist Lymphoma and multiple myeloma account for more than 65 percent of newly diagnosed hematological cancer cases. The genetic landscape of these [...]

1 Feb, 2021

Introduction to Liquid Biopsies

Introduction to Liquid Biopsies Maik M. Pruess, PhD Sr. Field Application Scientist The liquid biopsy is a relatively new concept that has gained traction over the last several years. Circulating tumor DNA (ctDNA) fragments are released by tumor cells into the blood, and contain [...]

1 Feb, 2021

Current Challenges in Liquid Biopsies

Current Challenges in Liquid Biopsies Maik M. Pruess, PhD Sr. Field Application Scientist The liquid biopsy has the potential to change cancer research and clinical care through a variety of applications, from early detection and monitoring, to detection of drug resistance and minimal residual [...]

30 Nov, 2020

2020 EACR Liquid Biopsies Sponsored Symposia

2020 EACR Liquid Biopsies Sponsored Symposia NeXT Liquid Biopsy, A High Performance, Exome-Wide Liquid Biopsy Assay to Study Tumor Dynamics Erin Newburn, PhD Associate Director, Field Applications Scientist Dan Norton, MBA Sr. Product Manager NeXT Liquid Biopsy™, a first-of-its-kind, high-performance exome-wide [...]

25 Jun, 2020

2020 Breast Cancer Summit Presentation

2020 Breast Cancer Summit Presentation Enabling multidimensional tumor immunogenomics for advancing biomarker discovery Christelle Johnson, PhD Senior Field Application Scientist Enabling multidimensional tumor immunogenomics for advancing biomarker discovery  Insight into the complex and dynamic interactions between the tumor and immune cells of the microenvironment is essential for cancer immunotherapy translational studies Purpose built [...]

25 Jun, 2020

2020 EACR Virtual Congress: Industry Symposium

2020 EACR Virtual Congress: Industry Symposium Enabling Composite Biomarker Discovery for Precision Cancer Therapy with an Enhanced Exome and Transcriptome Platform Erin Newburn, MS, PhD Director, Field Application Scientist Enabling Composite Biomarker Discovery for Precision Cancer Therapy with an Enhanced Exome and Transcriptome Platform In this presentation, we’ll provide an overview of the [...]

30 Jul, 2019

Biomarker Challenge #2: Analysis of Complex Data

Biomarker Challenge #2: Analysis of Complex Data More accurate, predictive biomarker analysis may assist in the selection of effective combinatorial immunotherapy treatments for patients.  Additionally, the complexity of both the tumor and tumor microenvironment suggests a comprehensive approach is needed for robust characterization of the cancer ecosystem. The ImmunoID NeXT™ platform investigates key aspects [...]

10 Jul, 2019

Biomarker Challenge #1: Limited Samples

Challenge #1: Comprehensive Biology from a Limited & Difficult Sample More accurate, predictive biomarker analysis may assist in the selection of effective combinatorial immunotherapy treatments for patients.  Additionally, the complexity of both the tumor and tumor microenvironment suggests a comprehensive approach is needed for robust characterization of the cancer ecosystem. The ImmunoID NeXTTM [...]

Go to Top